Share

Randomized, double-blind, placebo-controlled clinical trial to evaluate the effect and safety of oral semaglutide in subjects with early Alzheimer's disease (EVOKE)

Project objectives

The project has the general objective of evaluating the safety and efficacy of the drug semaglutide in patients with Alzheimer's disease.

Start and end date

Ongoing

Project Manager

Prof. Vincenzo Di Lazzaro - Principal Investigator

Coordinating institution of the project

UCBM

Other Institutions involved

  • Multicenter clinical trial

Funding source(s).

• NovoNordisk
magnifiercrossmenuchevron-downchevron-leftchevron-right